ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKER01

Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia

Active
Institution
CEDARS-SINAI MEDICAL CENTER, CA
Principal investigator
Joshua John Breunig
Funding
$463K
Duration
2024–2028
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY / ABSTRACT The cerebellum is an exquisitely laminated structure regulating balance, voluntary motor coordination and modulating language and cognition through connections with the forebrain. Sitting just under the forebrain, the cerebellum is estimated to contain roughly 80% of the neurons in the human brain. Accordingly, cerebellar dysgenesis, pathology, or dysfunction is associated with a host of diseases or disorders, including ataxia, autism, and intellectual deficit. Most cerebellar neurons are a subtype called cerebellar granule cells (CGCs), which are generated embryonically from a structure termed the rhombic lip (RL)—a germinal zone residing at the interface between the ventricular zone (VZ) and roof plate of the fourth ventricle. The mechanisms leading to the specification of the RL germinal niche and subsequent generation of granule cells remain incompletely understood. Specifically, the epigenetic and transcriptomic changes underlying how the ventricular zone precursor cells take on the lineage fate of the RL are largely unknown. We have generated a novel conditional knockout (cKO) mouse for TOX3, a member of the TOX family of transcription factors previously associated with the regulation of epigenetics in T cells. Loss of TOX3 prior to RL specification leads to almost complete agenesis of CGCs and 100% penetrant ataxia. We hypothesize that TOX3 mediates an epigenetic switch necessary for the generation of cerebellar granule cell precursors from the rhombic lip and associated ventricular zone—the loss of which results in developmental ataxia. Using a combination of state-of-the- art single cell approaches spanning key developmental time points in this murine model system, we will uncover the mechanisms by which TOX3 regulates cerebellar histogenesis. We propose to carry out this work in two parts. The focus of Specific Aim 1 is to interrogate the epigenetic and transcriptomic consequences of cKO of Tox3 using CUT&RUN for histone marks, and multimodal single- cell RNA- and ATAC-sequencing to determine genetic networks regulating VZ/RL precursors and CGC genesis. The main goal of Specific Aim 2 is to define the role of TOX3 on murine cerebellar lineages using inducible Cre drivers and somatic mutagenesis.

Research team

  • Joshua John BreunigPI
  • Jonathan G KayePI

LOADING MOONBASE SCORE

R01NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKENeurogenesis and Cell Fate Study Section[NCF]ventricularcerebellargerminalataxiazonegranulelipcko

Questions for CEDARS-SINAI MEDICAL CENTER

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.